This collaboration will streamline the ordering and delivery of molecular tests, enabling healthcare providers to electronically order and track Prolaris and MyRisk tests, with results delivered ...
Myriad Genetics (MYGN) and Lumea have signed an agreement to integrate Myriad’s advanced molecular diagnostic tests – Prolaris Prostate Cancer ...
The American Cancer Society estimates by 2050, the number of cancer cases globally will reach 35 million, a statistic medical ...
Navitas Semiconductor (Nasdaq: NVTS), the industry leader in next-generation GaNFast gallium nitride (GaN) and GeneSiC ...
The collars the cows wear for monitoring activity mean he is breeding off his best animals all the time to improve his ...